Incidence, risk factors and estimates of a woman's risk of developing secondary lower limb lymphedema and lymphedema-specific supportive care needs in women treated for endometrial cancer

Gynecologic Oncology

Volumn 136, Issue 1, 2015, Pages 87-93

  Beesley, Vanessa L ^a   Rowlands, Ingrid J ^a   Hayes, Sandi C ^b   Janda, Monika ^b   O'Rourke, Peter ^a   Marquart, Louise ^a   Quinn, Michael A ^c   Spurdle, Amanda B ^a   Obermair, Andreas ^d   Brand, Alison ^e   Oehler, Martin K ^f   Leung, Yee ^g   McQuire, Lesley ^h   Webb, Penelope M ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^e WESTMEAD HOSPITAL   (Australia)

^f ROYAL ADELAIDE HOSPITAL   (Australia)

^g UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^h University of Western Australia ^*  (Australia)

Author keywords

Endometrial cancer; Lower limb lymphedema; Risk factors; Unmet needs

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; BODY MASS; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER THERAPY; DRUG USE; ENDOMETRIUM CANCER; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LAPAROTOMY; LYMPH NODE DISSECTION; LYMPHEDEMA; MAJOR CLINICAL STUDY; MIDDLE AGED; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; AUSTRALIA; ENDOMETRIAL NEOPLASMS; INCIDENCE; LEG; NEEDS ASSESSMENT; PALLIATIVE THERAPY; PATHOLOGY; PROCEDURES; STATISTICAL MODEL;

AGED; AUSTRALIA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; LEG; LOGISTIC MODELS; LYMPHEDEMA; MIDDLE AGED; NEEDS ASSESSMENT; PALLIATIVE CARE; RISK FACTORS;

EID: 84925230367     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.11.006     Document Type: Article

References (28)

1. Australian Institute of Health and Welfare. Cancer in Australia: an overview, 2006. Canberra: Australian Institute of Health and Welfare; 2007.
2. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet 2005;366(9484):491-505.
3. Fung-Kee-Fung M, Dodge J, Elit L, Lukka H, Chambers A, Oliver T. Follow-up after primary therapy for endometrial cancer: a systematic review. Gynecol Oncol 2006;101(3):520-9.
4. Kitchener H, Swart AMC, Qian Q, Amos C, Parmar MKB. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009;373(9658):125-36.
5. Blake P, Swart AM, Orton J, Kitchener H, Whelan T, Lukka H, et al. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and metaanalysis. Lancet 2009;373(9658):137-46.
6. Cheville AL, McGarvey CL, Petrek JA, Russo SA, Thiadens SRJ, Taylor ME. The grading of lymphedema in oncology clinical trials. Semin Radiat Oncol 2003;13(3):214-25.
7. Ryan M, Stainton MC, Slaytor EK, Jaconelli C, Watts S, Mackenzie P, et al. Aetiology and prevalence of lower limb lymphoedema following treatment for gynaecological cancer. Aust N Z J Obstet Gynaecol 2003;43(2):148-51.
8. Paskett ED, Dean JA, Oliveri JM, Harrop JP. Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: a review. J Clin Oncol 2012;30(30):3726-33.
9. Abu-Rustum NR, Alektiar K, Iasonos A, Lev G, Sonoda Y, Aghajanian C, et al. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecol Oncol 2006;103(2):714-8.
10. Tada H, Teramukai S, Fukushima M, Sasaki H. Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma. BMC Cancer 2009;9:47-47.
11. Todo Y, Yamamoto R, Minobe S, Suzuki Y, Takeshi U, Nakatani M, et al. Risk factors for postoperative lower-extremity lymphedema in endometrial cancer survivors who had treatment including lymphadenectomy. Gynecol Oncol 2010;119(1):60-4.
12. Ghezzi F, Uccella S, Cromi A, Bogani G, Robba C, Serati M, et al. Lymphoceles, lymphorrhea, and lymphedema after laparoscopic and open endometrial cancer staging. Ann Surg Oncol 2012;19(1):259-67.
13. Hareyama H, Ito K, Hada K, Uchida A, Hayakashi Y, Hirayama E, et al. Reduction/prevention of lower extremity lymphedema after pelvic and para-aortic lymphadenectomy for patients with gynecologic malignancies. Ann Surg Oncol 2012;19(1):268-73.
14. Yost KJ, Cheville AL, Al-Hilli MM, Mariani A, Barrette BA, McGree ME, et al. Lymphedema after surgery for endometrial cancer: prevalence, risk factors, and quality of life. Obstet Gynecol 2014;124(2 Pt 1):307-15.
15. Beesley V, Janda M, Eakin E, Obermair A, Battistutta D. Lymphedema after gynecological cancer treatment: prevalence, correlates and supportive care needs. Cancer 2007;109(12):2607-14.
16. Ryan M, Stainton MC, Jaconelli C, Watts S, MacKenzie P, Mansberg T. The experience of lower limb lymphedema for women after treatment for gynecologic cancer. Oncol Nurs Forum 2003;30(3):417-23.
17. Rowlands IJ, Nagle CM, Spurdle AB, Webb PM. Gynecological conditions and the risk of endometrial cancer. Gynecol Oncol 2011;123(3):537-41.
18. Rowlands IJ, Weinstein P, Nagle CM, Spurdle AB, Webb PM. Season of birth and risk of endometrial cancer. Asian Pac J Cancer Prev 2011;12(5):1193-6.
19. Olsen CM, Bain CJ, Jordan SJ, Nagle CM, Green AlC, Whiteman DC, et al. Recreational physical activity and epithelial ovarian cancer: a case-control study, systematic review, and meta-analysis. Cancer Epidemiol Biomarkers Prev 2007;16(11):2321-30.
20. Beesley V, Price M, Butow P, Green A, Olsen C, Webb P, Australian Ovarian Cancer Study, AOCS-QoL Study Investigators. Physical activity in women with ovarian cancer and its association with decreased distress and improved quality of life. Psychooncology 2011;20(11):1161-9.
21. DHAC (Department of Health Aged Care), GISCA (National Key Centre for Social Applications of Geographic Information Systems). Measuring remoteness: accessibility/remoteness index of Australia (ARIA). Occasional papers: new series no. 14. Canberra: DHAC; 2001.
22. Australian Bureau of Statistics. Socio-economic indexes for areas 2001 (SEIFA 2001);2001 [Canberra].
23. Disipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 2013;14(6):500-15.
24. Hayes S, Janda M, Cornish B, Battistutta D, Newman B. Lymphedema secondary to breast cancer: how choice of measure influences diagnosis, prevalence, and identifiable risk factors. Lymphology 2008;41(1):18-28.
25. Hayes S, Johansson K, Stout N, Prosnitz R, Armer J, Gabram S, et al. Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care. Cancer 2012;118(Suppl. 8):2237-49.
26. Bernas MJ, Askew RL, Armer JM, Cormier JN. Lymphedema: how do we diagnose and reduce the risk of this dreaded complication of breast cancer treatment? Curr Breast Cancer Rep 2012;2(1):53-8.
27. Moffatt C, Doherty D, Morgan P. Lymphoedema framework: best practice for the management of lymphoedema. International consensus. London: MEP Ltd; 2006.
28. Girgis A, Stacey F, Lee T, Black D, Kilbreath S. Priorities for women with lymphoedema after treatment for breast cancer: population based cohort study. BMJ 2011;342 [p. d3442-d3442].